Psychosis in the elderly

Am J Psychiatry. 2009 Feb;166(2):146-50. doi: 10.1176/appi.ajp.2008.08020294.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Alzheimer Disease / complications
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / psychology
  • Antidepressive Agents, Second-Generation / adverse effects
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Aripiprazole
  • Combined Modality Therapy
  • Comorbidity
  • Cyclohexanols / adverse effects
  • Cyclohexanols / therapeutic use*
  • Delirium / diagnosis
  • Delirium / drug therapy
  • Delirium / psychology
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / psychology
  • Diagnosis, Differential
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Humans
  • Memantine / adverse effects
  • Memantine / therapeutic use
  • Nootropic Agents / adverse effects
  • Nootropic Agents / therapeutic use
  • Piperazines / adverse effects
  • Piperazines / therapeutic use*
  • Psychotherapy
  • Psychotic Disorders / diagnosis
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / psychology
  • Quinolones / adverse effects
  • Quinolones / therapeutic use*
  • Risk Factors
  • Treatment Outcome
  • Venlafaxine Hydrochloride

Substances

  • Antidepressive Agents, Second-Generation
  • Antipsychotic Agents
  • Cyclohexanols
  • Nootropic Agents
  • Piperazines
  • Quinolones
  • Venlafaxine Hydrochloride
  • Aripiprazole
  • Memantine